Priyamvada Natarajan Quotes

The old ethic for medicine [regarding new drugs] used to be: Is it safe and what are the risks? That is no longer adequate. Now people ask, "What goal are we reaching for?

Chemotherapy is just medieval. It's such a blunt instrument. We're going to look back on it like we do the dark ages.

Scientists have established huge numbers of links between particular diseases and snippets of DNA, but in the great majority of cases, this has not yet been translated into treatments that can help cure patients. These treatments will come - tomorrow, or the day after.

I agree, the world would be a better place if doctors were less enthusiastic about adopting very new drugs.

Over the years, HIV/AIDS activists and their allies have been pioneers in creating new frontiers in the medical establishment. Through their efforts, the FDA drug approval procedures were reformed so promising new therapies could reach desperate patients quicker.

It took 23 years from Abraxane being conceived to us showing now with conclusiveness that it works in pancreatic cancer. We cannot afford as a society to wait another 23 years to make sure that the patients get the right care, at the right time, at the right place.

By acquiring Biovex, we're continuing the transformation of Amgen into a company that supports therapeutic oncology as well as supportive care oncology.

Patients want to be seen as people. For me, the person's life comes first; the disease is simply one aspect of it, which I can guide my patients to use as a redirection in their lives. When doctors look at their patients, however, they are trained to see only the disease.

I think that in the 21st century, medical biology will advance at a more rapid pace than before.

My goals over the decade include to develop new drugs to treat intractable diseases by using iPS cell technology and to conduct clinical trials using it on a few patients with Parkinson's diseases, diabetes or blood diseases.

New drugs and surgical techniques offer promise in the fight against cancer, Alzheimer's, tuberculosis, AIDS, and a host of other life-threatening diseases. Animal research has been, and continues to be, fundamental to advancements in medicine.

We can get much better outcomes from people if we understand the genetic basis of the exact cancer that they have, what interventions might be most effective against it, what's worked in the past and what hasn't.

I don't want 100 different cures of cancer. I want, you know, give me five. So if you had, you know, five medicines, you could do away with 90 percent of cancer. That's sort of my objective. I think we're going to do it.

The interpretation of medicine today is 'do your clinical values fall within a normal range?' Everything in the globe right now is in the law of averages, which mean absolutely nothing to individuals.

In fast moving fields like cancer, where doctors tailor treatments based on evidence that's constantly evolving, two years can be an eternity of waiting to learn about important science. For some patients, that interval can be fatal.

I'm not the typical doctor that gives patients what they want. I don't do that. I try to give them what I want as long as they're okay with that. I know what's going to match their face.

I'm a strong believer in modern medicine. I think it has its use in society. I think it adds longevity to our life expectancy.

While I am prepared to look at all options and to think 'outside the box' for effective treatments, I rightly resisted efforts to provide an unproven drug on demand to the American public.

If we can validate our scientific bets in the clinic, if we can bring valuable new treatments to patients that need them, that will be our ultimate measure of success.

Patients with fatal diseases are fighting for their lives every day while real, meaningful, life-extending treatments sit on the shelf just beyond their reach.

In 2001, a systematic review of five studies revealed that roughly half of all chiropractic patients experience temporary adverse effects, such as pain, numbness, stiffness, dizziness and headaches. These are relatively minor effects, but the frequency is very high, and this has to be weighed against the limited benefit offered by chiropractors.

When you look at the growth of the human economy and its expected growth in the twenty-first century, I expect health will be the most important market of all. Especially as we move from a concept of health which focuses on healing the sick to a concept of upgrading the healthy.

So many of us have friends or family who have battled cancer, and we know how important it is to find a cure.

We need an NHS with fewer managers, fewer contractors and more power (rather than choice) to patients - with the input of the real experts: healthcare professionals.

My choice of learning pharmacy was driven by my interests, curiosity, and a desire to seek new medicines for patients.